Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01207193|
Recruitment Status : Completed
First Posted : September 22, 2010
Last Update Posted : December 14, 2011
There are two types of bone cysts, unicameral and aneurismal. These cysts happen to anyone, but they are most commonly seen in children and young adults while their bones are still growing. Living with a bone cyst and determining treatment options depend on the type of cyst.
Non-surgical treatments for unicameral bone cysts involves repeated X-rays in individuals who do not experience any symptoms.
Surgical removal of a unicameral bone cyst is needed if it becomes especially painful, or the area of the bone starts to thin out. The investigators aim to assess the clinical efficacy and side effects of mesenchymal stem cells seeded on bone matrix in repairing bone cyst.
|Condition or disease||Intervention/treatment||Phase|
|Bone Cyst||Biological: cell injection||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Reconstructing Bone Defects.|
|Study Start Date :||October 2009|
|Actual Primary Completion Date :||October 2011|
|Actual Study Completion Date :||December 2011|
Experimental: bone cyst
Patients with bone cyst defect are injected with mesenchymal cells.
Biological: cell injection
injection of mesenchymal cells to bone cyst defect
Other Name: cell transplantation
- fulfill bone cyst defect [ Time Frame: 6 months ]Defect of bone due to cyst fulfill after cell transplantation.
- effect of mesenchymal cell transplantation [ Time Frame: 6 months ]Evaluate effect of mesenchymal cell transplantation to fulfill the defect of bone cyst.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01207193
|Iran, Islamic Republic of|
|Tehran, Iran, Islamic Republic of|
|Study Chair:||Hamid Gourabi, PhD||President of Royan Institute|
|Study Director:||Mohammad reza Baghban Eslami Nejad, PhD||Scientific Board|
|Principal Investigator:||Mohssen Emadeddin, MD||Orthopedic Investigator|
|Study Director:||Ahmad Vosough, MD||Radiologist investigator|
|Principal Investigator:||Nasser Aghdami, MD,PhD||Head of regenerativ center|